Status:
RECRUITING
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Lead Sponsor:
Mingzhao Xiao
Conditions:
Clear Cell Renal Cell Carcinoma
Prognostic Cancer Model
Eligibility:
All Genders
Brief Summary
This study aims to preoperatively predict DFS of patients with localised ccRCC using a deep learning prognostic model based on enhanced contrast CT images, validate it's predictive ability in multicen...
Eligibility Criteria
Inclusion
- underwent partial/radical nephrectomies
- histologically diagnosed as ccRCC
- with complete clinical data and preoperative CT image data
Exclusion
- with incomplete clinic-pathological data
- lack of preoperative contrast-enhanced CT images or the image quality was unsuitable for analysis
- who received pre-surgery neoadjuvant or adjuvant therapies
- with multiple renal tumors or/and had synchronous metastasis
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06088134
Start Date
September 1 2022
End Date
August 1 2025
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yingjie Xv
Chongqing, Chongqing Municipality, China, 400016